Cadrenal Therapeutics (CVKD) Institutional Ownership $17.60 +0.64 (+3.77%) (As of 11/1/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Cadrenal Therapeutics (NASDAQ:CVKD)CurrentInstitutional OwnershipPercentage7.92%Number ofInstitutional Buyers(last 12 months)1Number ofInstitutional Sellers(last 12 months)2 Get CVKD Insider Trade Alerts Want to know when executives and insiders are buying or selling Cadrenal Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Cadrenal Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/9/2024Renaissance Technologies LLC59,491$28K0.0%-59.8%0.372% 2/13/2024Armistice Capital LLC414,285$307K0.0%-57.8%3.182% 11/15/2023Armistice Capital LLC982,285$668K0.0%N/A7.544% (Data available from 1/1/2016 forward) CVKD Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CVKD shares? During the previous two years, the following institutional investors and hedge funds held shares of Cadrenal Therapeutics shares: Armistice Capital LLC ($307K), Renaissance Technologies LLC ($28K).Learn more on CVKD's institutional investors. What percentage of Cadrenal Therapeutics stock is owned by institutional investors? 7.92% of Cadrenal Therapeutics stock is owned by institutional investors. Learn more on CVKD's institutional investor holdings. Which institutional investors have been buying Cadrenal Therapeutics stock? The following institutional investors have purchased Cadrenal Therapeutics stock in the last 24 months: Armistice Capital LLC ($982.29K). How much institutional buying is happening at Cadrenal Therapeutics? Institutional investors have bought a total of 982,285 shares in the last 24 months. This purchase volume represents approximately $0.00 in transactions. Which Cadrenal Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Cadrenal Therapeutics stock in the last 24 months: Armistice Capital LLC ($568K), and Renaissance Technologies LLC ($88.65K). How much institutional selling is happening at Cadrenal Therapeutics? Institutional investors have sold a total of 656,647 shares in the last 24 months. This volume of shares sold represents approximately $0.00 in transactions. Related Companies ANL Institutional Ownership DBVT Institutional Ownership ZIVO Institutional Ownership PRLD Institutional Ownership CTXR Institutional Ownership QNCX Institutional Ownership DTIL Institutional Ownership CNTB Institutional Ownership ENTX Institutional Ownership SPRO Institutional Ownership This page (NASDAQ:CVKD) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cadrenal Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cadrenal Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
